Used primarily as an anticancer agent, it targets tumor cell metabolism by inhibiting glycolysis and mitochondrial function, particularly in aggressive cancers. It has been investigated in clinical trials for brain, prostate, and breast cancers, often in combination with chemotherapy or radiation to enhance tumor sensitivity. Also studied for male contraceptive use due to its ability to inhibit sperm motility and energy production, though this application remains experimental. Shows potential in overcoming drug resistance in cancer therapy by modulating cellular energy pathways.